Intravenous immunoglobulin for the treatment of Kawasaki disease

Overview of attention for article published in Cochrane database of systematic reviews, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 34 X posts from 29 X users, with an upper bound of 104,860 followers.

RT @CochraneNursing: What is the effectiveness & safety of intravenous #immunoglobulin in treating #KawasakiDisease and preventing its card…

RT @CochraneNursing: What is the effectiveness & safety of intravenous #immunoglobulin in treating #KawasakiDisease and preventing its card…

RT @CochraneNursing: What is the effectiveness & safety of intravenous #immunoglobulin in treating #KawasakiDisease and preventing its card…

RT @CochraneNursing: What is the effectiveness & safety of intravenous #immunoglobulin in treating #KawasakiDisease and preventing its card…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 30 additional X posts.